Morgan Stanley 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-07 11:25 am Sale | 2025-03-31 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Morgan Stanley MS | 2,040,013 2.400% | -3,322,156 (-61.96%) | Filing |
| 2025-02-05 10:03 am Purchase | 2024-12-31 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Morgan Stanley MS | 5,362,169 6.300% | 5,362,169 (New Position) | Filing |